# Trade Mark Journal No.2026/017 24 April 2026

## WO0000001911596 (5)

Office of origin: United States of America

Date of International Registration:10 March 2026
Date of designation in the UK: 10 March 2026

International priority date claimed: 8 October 2025 (United States of America) (99432997)

Class 5
  Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders.

Nuvalent, Inc.

Representative: Joshua S. Jarvis Foley Hoag LLP, 155 Seaport Blvd., Boston MA 02210-2600, UNITED STATES OF AMERICA